Label: BLT 3- tetracaine ointment
- NDC Code(s): 70372-729-01
- Packager: CENTURA PHARMACEUTICALS INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 4, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- USES
-
WARNINGS
• For external use only.
• Avoid contact with eyes or mucus membranes.
• Do not apply to open or damaged skin.
• If condition worsens or symptoms persist for
more than seven days, discontinue use and
consult physician.
• If pregnant or breast feeding,contact physician
prior to use.
• Keep out of reach of children. If swallowed,
contact Poison Control Center.
• Do not use if allergic to any ingredient in ointment.
• Do not use in large quantities, particularly over
raw surfaces or blistered areas. - DIRECTIONS
- OTHER INFORMATION
- INACTIVE INGREDIENTS
- KEEP OUT OF REACH OF CHILDREN
- PACKAGE LABELING
-
INGREDIENTS AND APPEARANCE
BLT 3
tetracaine ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:70372-729 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV) TETRACAINE 2 g in 100 g Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) PEG-100 STEARATE (UNII: YD01N1999R) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA) PEG-8 STEARATE (UNII: 2P9L47VI5E) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70372-729-01 5 g in 1 POUCH; Type 0: Not a Combination Product 10/30/2016 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M017 10/30/2016 Labeler - CENTURA PHARMACEUTICALS INC (084921637) Registrant - CENTURA PHARMACEUTICALS INC (084921637)